Eli Lilly to Carry Out 2nd Clinical Trial for Alzheimer’s Drug
Eli Lilly, an Indianapolis drug maker, has come up with an experimental drug to treat mild cases of Alzheimer's. The drug named as solanezumab is said to have brought a hope to slow the memory decline among Alzheimer's.
However, it seems that doctors and patients will have to wait for couple of years, as the drug maker still has to get green signal from regulators. It has also been found that it is also going to take out a new clinical trial, which is second in the row.
The second clinical trial is said to be initiate from the third quarter of 2013. Concerns were raised when it was found that the drug has failed to reduce the memory loss. But, when it combined the results of two trails, it was found that the drug has reduced mobile loss.
In order to confirm the result, the drug maker is going to carry out a new clinical trial. After knowing the result of the same, the drug maker will see permission from the regulators for marketing the drug.
"We are committed to working with the FDA and other regulatory authorities to bring solanezumab to millions of patients and caregivers suffering from this devastating disease", said David Ricks, Senior Vice-President at Lilly.
European Commission President Jean-Claude Juncker’s proposal to expand Eurozone by bringing more countries into it has triggered controversy, mainly in Germany, where Chancellor Angela Merkel is seeking re-election.
Wall Street soared to record highs on Friday, thanks to robust trading in telecommunication shares as well as bouncing back of technology shares after a couple of days of declines.
The European Union’s effort to increase tax on turnover of technology multinationals like Google and Amazon gained momentum as nearly one third of EU states are now in support of the plan, French Finance Minister Bruno Le Maire said on Friday.
Stock price of electric vehicle maker Tesla gained more than 3 per cent on Thursday, after the company’s founder and CEO Elon Musk confirmed plans to introduce an electric semi-truck.
Bitcoin suffered its steepest decline since January 2015 on Friday after a senior executive of China’s state-backed internet finance body said the controversial digital currency could pose risks because Bitcoins and other cryptocurrencies could be
Cupertino, California-based Apple Incorporated has quietly increased prices for the 256GB and 512GB models of its iPad Pro by $50, MacRumors reported.